chrisvoncsefalvay/vaers-outcomes huggingface dataset:
December 20, 5 days after getting the vaccine I got swelling in my legs, it increased over time and in about two weeks gained 19 pounds of weight from swelling. Its specifically more in my left leg and the left side of my stomach, I have it slightly on the right side. Now this swelling could be do to one of the insulin shots or just from being diabetic. December 16-22 about that length in time, I had redness and a rash about around the injection site. It was about a quarter size at first and then it slowly increased to about of the bottom of a soda can. It was not circular but that's the best to describe how big the redness got. There was a hard bump feeling closer to injection site. All the red area was warm to touch, sometimes it was itchy.
This spontaneous report as received from a medical assistant refers to a patient of an unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant medications was provided. On 23-JUN-2016, the patients received dose of improperly stored VAQTA with lot # M011116 and expiration date 17-MAY-2017, via intramuscular route (dose was not reported). Administered dose underwent temperature excursions at 31 Fahrenheit degrees, for 10 hours. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information is not expected.
Swelling along the axillary lymphnodes of the left arm, swelling along the lateral neck lymphnodes, clavicle and chest.  Acute fatigue.
Inflammatory Polyarthropathy/ramdom and diffuse body pain; Paresthesia; Neuroma; Peripheral Neuropathy; Raynaud's Phenomenon; Fibromyalgia; Severe fatigue; Brain fog; Menstrual dysfunction; Autoimmune and Neurological injuries; Autoimmune and Neurological injuries; Problems with memory; Aconstellation of adverse symptoms, complications, injuries and other adverse events; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a 26-year-old female patient. The patient's concurrent conditions, medical history and concomitant medication were not provided.  Upon diagnosis of a suspect pap smear, patient health care provider, recommended quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) vaccination. On 15-MAY-2019, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) (Lot #, expiration date, dose, route of administration and anatomical location of vaccine were not provided) for preventing cervical cancer. The patient second dose was administered in 23-OCT-2019.On an unspecified date, following vaccination, the patient started experiencing, sustained serious autoimmune and neurological injuries as a result of her vaccination it began with a random and diffuse body pain, which persisted over time. After seeing numerous specialists, the patient was diagnosed with various medical conditions, including but not limited to, inflammatory polyarthropathy, paresthesia, neuroma, peripheral neuropathy, Raynaud's phenomenon, fibromyalgia, severe fatigue, brain fog, and menstrual dysfunction. As a result of her symptoms, the patient had been unable to engage in normal activities. Following the vaccinations, the patient physical symptoms made attending college difficult. Also, she had problems with memory and brain fog, all of which was interfering with her daily life, making the simplest task, more difficult to perform.As a proximate result of vaccination, the patient  suffered and continues to suffer severe and permanent physical injuries, and associated symptomology and has suffered severe and permanent emotional injuries, including pain and suffering. Patient also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL).As a direct and proximate result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) l-induced injuries, the patient had suffered and continues to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity and she will continue to incur these losses and expenses in the future. The events outcome was not recovered. The reporter considered the events to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL)   Upon internal review the event of Autoimmune disorder was considered as medically significant.
vaccinated 01/13/2021, at  0830. Her co-worker called down this afternoon and reported that sometime between 11:30 am and noon, Patient started having cold sweats, nausea, low grade temp, and body aches. She did vomit once, but had just eaten lunch.
Patient came to Pharmacy on 4/8/21 wanting something for pain and inflammation for her wrist stating that she thought she was getting a flare of her lups  due to the covid 19 vaccine Pfizer.  I recommend she speak to her doctor.
The patient presented to the Emergency Department several hours after receiving their first dose of Pfizer's COVID-19 vaccine. EMS evaluated at the vaccine site, but the patient refused transport and elected to drive themselves. In the ED, the patient reported heart palpitations, "seeing spots", chest discomfort, itching on their chest, and HTN. On presentation, the patient was tachycardic (120bpm) and hypertensive (185/95). The patient's labs and tests were not concerning, and the physician stated the patient was well-appearing and in no acute distress. The patient was discharged with diagnoses of possible reaction Pfizer COVID vaccine, Possible anxiety response, and Hypertension. The physician instructed the patient to regularly check their blood pressure and follow-up with their PCP.
Arm was sore at the injection site; This case was reported by a consumer and described the occurrence of injection site pain in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Flu vaccine with an associated reaction of injection site pain (received flu vaccine on an unknown date, refer case US2021AMR013295).   In September 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   The reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient The age at vaccination was not reported. The reporter did not have the lot/expiration date but did provide contact information for his pharmacy. The patient received Shingrix shot 1 in September 2020. The patient stated that his arm was sore at the injection site. For tolerance of 2nd dose refer case US2021AMR013283. This case is linked to the US2021AMR013295 same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR013283:Same reporter. US-GLAXOSMITHKLINE-US2021AMR013295:Same reporter.
face, with periorbital swelling and wheezing  38 to 45 hours post vaccine,      to sore throat started 24 hours after vaccine .  Severe headache and joint pain started 27 hours after vaccine
re admission 3/1/2022 admitted on 2/27/22 for recurrent falls and alerted mental status. Family had noted increased confusion, weakness, and urinary incontinence in the last week.  COVID positive on 2/26, asymptomatic
This spontaneous report as received from a Licensed Vocations Nurse regarding unspecified patients of unknown demographics. There was no information about pertinent medical history, drug reactions or drug allergies. On 10-AUG-2015, the patients were vaccinated with 2 doses of improperly stored doses of (Merck) PROQUAD lot# L003221 and expiry date: 30-JUL-2016. No adverse effect was reported. The outcome of the event was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
Local reaction - 9cmx11cm warm, red, tender, swollen, indurated area, myalgias, chills, headache. Treatment - warm compress, Keflex 500mg QID for 10 days.
Vaccine given 10/16/15. On 10/17/15, parents report right arm (shoulder to mid-forearm) swelling, pain, redness, and itching that extended to the mid-chest and back. Parents report fever to 105 degrees F. Admitted to hospital on 10/19/15 with significant right arm swelling and suspected cellulitis.
Itching on left side of face with a mild rash, with a blister that popped with little blood.
Pins and needles and numbness in both feet and pin s and needles in calves off and on for a week and ongoing.
grandma stated pt was seen in ER 8MAR96 w/both legs black from hip to feet;pt had on long pants & discoloration noted when clothes were removed to put pt in bath tub;color got better p/putting in warm water but was taken to ER;21MAR96 flu;
Redness, swelling, soreness L deltoid Rocephin 500 mg x 1 dose 10/25/02.
Erythema multiforme minor with skin lesions on hands and feet starting 10 days after receiving the vaccine followed by hip, knee and lower back pain
Patient was given Engerix B 0-19 years of age instead of adult dosing. Patient did not have an adverse reaction.
This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Pfizer Dose One) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history reported).    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jan-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Pfizer Dose One). On 01-Jan-2021, INTERCHANGE OF VACCINE PRODUCTS (Pfizer Dose One) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Patient felt lightheaded,  and his brother laid him on the ground and then he passed out for a few seconds. Pt was responsive after but felt drowsy. Pt was given water felt better.  Per discussion with patient, he has a history of getting faint from seeing needles and getting blood drawn.
patient developed one large urticaria 2 days after immunization and diffuse urticaria 3 days after immunization
Raynauds syndrome left hand only; This is a spontaneous report from a contactable physician. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via intramuscular route of administration in the left arm on 28Apr2021 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient had no known allergies. On 30Apr2021, 2 days after injection, the patient experienced Raynaud's syndrome in left hand only where she never had this before. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Raynaud's syndrome in left hand was recovered on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
2 hours, post vax, pt had a fever, irritability and crying. Since, has had emesis, arm tremor, circumoral cyanosis, per mom. Seen in ER. Alert, crying and easily consoled. Force liquids.
12hr p/vax pt exp bronchospasm w/SOB & coughing;also devel an inj site rxn characterized by redness & swelling @ the site of vax;went to ER & noted to be in severe resp distress;pt hosp & treated w/nebulized albuterol, aminophyylline;
Started with a mild headache a few hours after injection . 14 hours after injection the following occurred over a 20 minute window.  Nausea then fainted and fell to floor.  Could not get up for about 15 mins due my body feeling very heavy (like a block of concrete).  I was eventually able to get up with help from my husband who walked me back to bed.  I became very cold (teeth chattering) and my husband had to put extra clothes on me as I was not able to dress myself.  If it wasn't the middle of the night, I might have called 911.  I was able to go back to sleep and woke up at 8:30 AM and worked until 4 (napped for about an hour and a half).  After that I felt pretty good except for lower back tightness and the mild headache which went away the next day.  No other symptoms after that.
Arm soreness one week after. Resolved with ibuprofen. After one week, patient attempted to stop ibuprofen and pain returned. Patient advised to see MD (who seen on 10/31/2020) and was diagnosed with frozen shoulder to be resolved with physical therapy.
Patient received first dose of moderna vaccine on 05/01/21 at clinic. Patient received second dose of moderna vaccine on 05/22/21 at clinic. Patient received second dose 7 days earlier than recommended 28 days after first shot. Patient waited required 15 mins after injection and did not have an adverse reaction. Called and notified CDC. Stated that patient did not need another dose. Sent email with CDC info on vaccine to clinic manager. Clinic Manager called patient's wife, apologized and  informed of situation. Relayed information that CDC had stated. Sent email with CDC information to patient's wife. Patient was witness over the phone.
pt recv vax 15AUG96;lt testicle uncomfortable since 27AUG96;painful & swollen;told to lie down elevate testicle w/cool pack;see MD if felt worse;saw urologist 3SEP96; given med;stated pt had epididymitis probable from some infect;
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history reported).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved.            No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-067082 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-067082:Dose 1
I had some adverse effects immediately after the 1st dose. I felt"sped up" and hyper and then got an almost"drunk" feeling. It lasted for 7 hours, then stopped, but I had general fatigue for 5 days, aches/pains.   After the 2nd shot,  I had similar reactions for 2 days, then I felt ok. 3 weeks later, though, I woke up to immense joint pain, lower leg pain, huge amount of fatigue and pain. The lower limb and joint pain was incredibly intense and pretty horrible. I still have pain in one leg currently. It's pretty severe and painful!
feeling crappy; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was recovered/resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingrix.     Additional Information: GSK Receipt Date: 10-DEC-2022 Reporter's Comments: The patient self-reported this case via interactive digital media. The patient said post-herpetic neuralgia was a pain syndrome that could last for the rest of your life even after the shingles rash was cleared.  The 8 to 10 hours of feeling crappy after his/her Shingrix shot was worth it.  It was one of the most effective vaccines out there.  The patient mentioned as his/her cousin died from shingles in his eye that spread to his brain after 3 weeks in a coma. Additional Supportive Information: The follow-up would not possible, as no contact, details were available.
Raised, painful rash diagnosed as Cellulitis on left shin and ankle; Rash aligned with shingles diagnostic pattern for lower leg; Rash aligned with shingles diagnostic pattern for lower leg; This is a spontaneous report from a non-contactable other healthcare professional.   A 44-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Right Arm on 17Feb2021, at the age of 44-years-old, (Lot Number: EN 5318) as DOSE 2, SINGLE for covid-19 immunisation.  The patient is not pregnant at the time of vaccination. Medical history included penicillin group allergy. Concomitant medication included acetylsalicylic acid (ASPIRIN 81) taken for an unspecified indication, start and stop date were not reported. Historical vaccine includes BNT162b2 (lot number: EN 5318) received on 25Jan2021 in right arm, dose 1, single. Prior to vaccination, the patient was not diagnosed with COVID-19. On Jun2021, the patient experienced raised, painful rash diagnosed as cellulitis on left shin and ankle; Rash aligned with shingles diagnostic pattern for lower leg (only reporting due to recent news of potential shingles events after vaccinations. The events involved emergency room/department or urgent care and physician office visit. Since the vaccination, the patient has not been been tested for COVID-19. Treatment was received for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
12 hrs after DTAP, Flu, HIB, Pneumococcal developed fever, 102, relative lethargy, decreased po intake. Temp fluctuating past 5 days still temp 103 at peak no nausea vomiting.
A FEW MIN. AFTER  I TOOK THE SHOT, MY BODY STARTED ITCHING..THE SECOND DAY I WOKE UP WITH ALOT OF SMALL RED ITCHY BUMPS ALL OVER MY BODY, IM THINKING THEIR HIVES
arm and hand started tingling; with the feeling of it falling asleep; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (arm and hand started tingling) and SOMNOLENCE (with the feeling of it falling asleep) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Johnson and Johnson on 20-Mar-2021. Past adverse reactions to the above products included No adverse event with Johnson and Johnson.    On 06-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Dec-2021, the patient experienced PARAESTHESIA (arm and hand started tingling) and SOMNOLENCE (with the feeling of it falling asleep). At the time of the report, PARAESTHESIA (arm and hand started tingling) and SOMNOLENCE (with the feeling of it falling asleep) had not resolved.            No concomitant medication were reported.  Patient had the Johnson and Johnson vaccine on 20-Mar-2021 and had the Moderna booster on 06-Dec-2021. On 08-Dec-2021 patient arm and hand started tingling with the feeling of it falling asleep and it continues on 09-Dec-2021.  No treatment medication were reported.
FIRST DOSE- FEELING HOT, CHILLS, TIREDNESS, MILD HEADACHE AND GENERAL BODY PAIN  SECOND DOSE-FEVER, CHILLS, SEVERE HEADACHE, ITCHY IN THE VACCINATION AREA AND PAIN IN THE VACCINE ARM AND RADIATES UNDER THE ARMPIT TO THE BREAST AND DIARRHEA
February I had itching, swelling, and a rash associated with shingles which was diagnosed by my doctor. It took a week of anti viral therapy for the shingles. I've had typical shingles after effects since.
Headache Narrative: Patient has been experiencing tension headaches 4 to 5 times a week since receiving her second dose of Moderna COVID vaccine. Patient has reported to rarely (2 a year) have headaches prior to COVID vaccine
heat travel up to my neck and my ears and around my face; left side of my tongue, cheek, lips, throat, all are numb; pins and needle feeling; My tongue and cheek are sick; the lower left side of my face was numb; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (heat travel up to my neck and my ears and around my face), HYPOAESTHESIA ORAL (left side of my tongue, cheek, lips, throat, all are numb), PARAESTHESIA (pins and needle feeling), FACIAL DISCOMFORT (My tongue and cheek are sick) and HYPOAESTHESIA (the lower left side of my face was numb) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 032M20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Novocaine shot. Past adverse reactions to the above products included Pins and needles with Novocaine shot.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced FEELING HOT (heat travel up to my neck and my ears and around my face), HYPOAESTHESIA ORAL (left side of my tongue, cheek, lips, throat, all are numb), PARAESTHESIA (pins and needle feeling) and HYPOAESTHESIA (the lower left side of my face was numb). 03-Apr-2021, the patient experienced FACIAL DISCOMFORT (My tongue and cheek are sick). At the time of the report, FEELING HOT (heat travel up to my neck and my ears and around my face), HYPOAESTHESIA ORAL (left side of my tongue, cheek, lips, throat, all are numb), PARAESTHESIA (pins and needle feeling), FACIAL DISCOMFORT (My tongue and cheek are sick) and HYPOAESTHESIA (the lower left side of my face was numb) was resolving.            No concomitant medications were reported. No treatment medications were reported. It was reported that no symptoms after first dose. It's really not awful Patient was afraid to get a booster, afraid to have this happened again and be really numb forever. Patient had  stroke assessment and there was no stroke. The doctor did not give her any treatment Patient experienced symptoms on her left side.
Within minute of shot patient complained of lightheaded. Approx 2 min after shot patient passed out for about a minute then regained consciousness. Felt horrible & still was disoriented. Patient skin got clammy. Squad was called & pt transported to hospital.
Redness and swelling 11 cm x 12 cm left upper arm with site of MMRV and moderate heart present.
Information has been received from a pharmacist concerning an adult female who was recently vaccinated with a dose of measles virus vaccine live +mumps virus vaccine live+ rubella virus vaccine. Subsequently, the patient developed joint pain and a low grade fever. Unspecified medical attention was sought. The patient was treated with acetaminophen (Tylenol).The pharmacist reported that another patient developed joint pain and low grade fever post vaccination with measles virus vaccine live +mumps virus vaccine live+ rubella virus vaccine . Additional information has been requested.
pt recv vax 4AUG95 & 10JUN96 pt presented to MD ofc w/papules & vesicles in various stages of face, trunk & extremities;approx 21 lesions;tx w/DPH & aveeno;pt exposed to chicken pox in daycare;
Redness, cellulitis at site of injection starting on day of injection 9/15/09, patient given BACTRIM DS TBID X 7 days and DECADRON 1cc.